Dow Up 0.12% Nasdaq Up 1.35%

Momenta Pharmaceuticals Inc. (MNTA)

-NasdaqGS
11.21 0.14(1.23%)
Prev Close:11.35
Open:N/A
Bid:10.66 x 100
Ask:11.50 x 100
1y Target Est:15.38
Beta:1.78
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:11.03 - 11.47
52wk Range:9.38 - 19.90
Volume:N/A
Avg Vol (3m):453,985
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-2.13
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for MNTA

Comparison

Symbol% ChgMkt Cap
MNTADown 1.23%N/A
GSKN/A
SNYN/A
TEVAN/A

Key Statistics

Forward P/E (1 yr):10.01
P/S (ttm):12.92
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.60
Quarterly EPS Est (Sep-14) :-0.43
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Momenta Pharmaceuticals, Inc., a biotechnology company, is engaged in the structural characterization, process engineering, and biologic systems analysis of complex molecules in the areas of complex generics, biosimilars, and novel drugs. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback